Eichhorst, B, Niemann, C U, Kater, A P, Fürstenau, M, von Tresckow, J, Zhang, C, Robrecht, S, Gregor, M, Juliusson, G, Thornton, P, Staber, P B, Tadmor, T, Lindström, V, da Cunha-Bang, C, Schneider, C, Poulsen, C B, Illmer, T, Schöttker, B, Nösslinger, T, Janssens, A, Christiansen, I, Baumann, M, Frederiksen, H, van der Klift, M, Jäger, U, Leys, M B L, Hoogendoorn, M, Lotfi, K, Hebart, H, Gaska, T, Koene, H, Enggaard, L, Goede, J, Regelink, J C, Widmer, A, Simon, F, De Silva, N, Fink, A-M, Bahlo, J, Fischer, K, Wendtner, C-M, Kreuzer, K A, Ritgen, M, Brüggemann, M, Tausch, E, Levin, M-D, van Oers, M, Geisler, C, Stilgenbauer, S, Hallek, M, German CLL Study Group (GCLLSG), Haemato-Oncology Foundation for Adults in the Netherlands (HOVON), Nordic CLL Study Groups, Swiss Group for Clinical Cancer Research (SAKK), The Israeli CLL Association & Cancer Trials Ireland 2023, ' First-Line Venetoclax Combinations in Chronic Lymphocytic Leukemia ', The New England Journal of Medicine, vol. 388, no. 19, pp. 1739-1754 . https://doi.org/10.1056/NEJMoa2213093
Vainer, N, Aarup, K, Andersen, M A, Wind-Hansen, L, Nielsen, T, Frederiksen, H, Enggaard, L, Poulsen, C B, Niemann, C U & Rotbain, E C 2023, ' Real-world outcomes upon second-line treatment in patients with chronic lymphocytic leukaemia ', British Journal of Haematology, vol. 201, no. 5, pp. 874-886 . https://doi.org/10.1111/bjh.18715
The Lancet Oncology, 23(6), 818-828. Lancet Publishing Group Kater, A P, Levin, M-D, Dubois, J, Kersting, S, Enggaard, L, Veldhuis, G J, Mous, R, Mellink, C H M, van der Kevie-Kersemaekers, A-M F, Dobber, J A, Poulsen, C B, Frederiksen, H, Janssens, A, Schjødt, I, Dompeling, E C, Ranti, J, Brieghel, C, Mattsson, M, Bellido, M, Tran, H T T, Nasserinejad, K & Niemann, C U 2022, ' Minimal residual disease-guided stop and start of venetoclax plus ibrutinib for patients with relapsed or refractory chronic lymphocytic leukaemia (HOVON141/VISION) : primary analysis of an open-label, randomised, phase 2 trial ', The Lancet Oncology, vol. 23, no. 6, pp. 818-828 . https://doi.org/10.1016/S1470-2045(22)00220-0 Lancet Oncology, 23(6), 818-828. ELSEVIER SCIENCE INC The Lancet. Oncology, 23(6), 818-828. Lancet Publishing Group
Blood, 137(8), 1117-1120. AMER SOC HEMATOLOGY Niemann, C U, Levin, M-D, Dubois, J, Kersting, S, Enggaard, L, Veldhuis, G J, Mous, R, Mellink, C H M, Dobber, J A, Poulsen, C B, Frederiksen, H, Janssens, A, Schjødt, I, Dompeling, E C, Ranti, J, Mattsson, M, Bellido, M, Tran, H T T, Nasserinejad, K & Kater, A P 2021, ' Venetoclax and Ibrutinib for Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia ', Blood, vol. 137, no. 8, pp. 1117-1120 . https://doi.org/10.1182/blood.2020008608 Blood, 137(8), 1117-1120. American Society of Hematology Niemann, C U, Levin, M-D, Dubois, J, Kersting, S, Enggaard, L, Veldhuis, G J, Mous, R, Mellink, C H M, Dobber, J A, Poulsen, C B, Frederiksen, H, Janssens, A, Schjødt, I, Dompeling, E C, Ranti, J, Mattsson, M, Bellido, M, Tran, H T T, Nasserinejad, K & Kater, A P 2021, ' Venetoclax and ibrutinib for patients with relapsed/refractory chronic lymphocytic leukemia ', Blood, vol. 137, no. 8, pp. 1117-1120 . https://doi.org/10.1182/blood.2020008608
Niemann, C U, Dubois, J, Brieghel, C, Kersting, S, Enggaard, L, Veldhuis, G J, Mous, R, Mellink, C, Dobber, J A, Poulsen, C B, Frederiksen, H, Janssens, A, Schjødt, I, Dompeling, E C, Juha Ranti, J, Mattsson, M, Bellido, M, Nasserinejad, K, Tran, H T T, Levin, M-D & Kater, A P 2021, ' Time-Limited Venetoclax and Ibrutinib for Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia (R/R CLL) Who Have Undetectable MRD – Primary Analysis from the Randomized Phase II Vision HO141 Trial ', Blood, vol. 138, no. Supplement 1, 69 . https://doi.org/10.1182/blood-2021-148630
Gade, I L, Riddersholm, S J, Christiansen, I, Rewes, A, Frederiksen, M, Enggaard, L, Poulsen, C B, Bergmann, O J, Gillström, D B, Pedersen, R S, Nielsen, L, Eriksen, H H, Torp-Pedersen, C, Kristensen, S R & Severinsen, M T 2018, ' Venous thromboembolism in chronic lymphocytic leukemia : a Danish nationwide cohort study ', Blood Advances, vol. 2, no. 21, pp. 3025-3034 . https://doi.org/10.1182/bloodadvances.2018023895 Gade, I L, Riddersholm, S J, Christiansen, I, Rewes, A, Frederiksen, M, Enggaard, L, Poulsen, C B, Bergmann, O J, Gillström, D B, Pedersen, R S, Nielsen, L, Eriksen, H H, Torp-Pedersen, C, Kristensen, S R & Severinsen, M T 2018, ' Venous thromboembolism in chronic lymphocytic leukemia : a Danish nationwide cohort study ', Blood advances, vol. 2, no. 21, pp. 3025-3034 . https://doi.org/10.1182/bloodadvances.2018023895